3650 results for «382»
3650 results
AICT-AsiaPCR 2024 Awards ceremony
05 Oct 2024 – From AICT-AsiaPCR 2024
Join us for this exciting awards ceremony, where you'll first meet the three winners selected from 322 candidates across 27 countries who received accolades for the best clinical cases. Witness the presentation of the award-winning case titled 'Percutaneous Intervention of Stuck Prosthetic Mitral Valve'. Following that,...
Complex STEMI cases: Dextrocardia, thrombosis and coronary aneurysms
05 Oct 2024 – From AICT-AsiaPCR 2024
Prepare to be captivated by a collection of intriguing STEMI cases, curated from the AICT-AsiaPCR 2024 submissions. From a left main PCI in a patient with dextrocardia to a challenging case of primary PCI in an aneurysmal coronary artery, this session promises to push the boundaries...
Bifurcation PCI with TAP technique - LIVE case
05 Oct 2024 – From AICT-AsiaPCR 2024
A 72-year-old lady with dyslipidemia, hypertension and aspirin intolerance presented an NSTEMI. The coronary angiography showed a distal CX occlusion and a long calcified significant stenosis on proximal LAD with LAD/D3 bifurcation lesion, and a reduced LV function (47%).
Watch the operators as they perform an important...
How should I treat complex lesion from the intracoronary imaging view?
05 Oct 2024 – From AICT-AsiaPCR 2024
Intracoronary imaging plays a crucial role in guiding treatment strategies for complex lesions. This session delves into the use of various imaging modalities, such as IVUS and OCT, to optimize PCI outcomes. Explore real-world case examples, including a sudden coronary arrest caused by focal stenosis with...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
02 Sep 2024
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.
Author
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
Evidence base: current data on TAVI durability and long-term outcomes
18 Jun 2026
This article reviews the current evidence on TAVI durability, focusing on long-term outcomes, device-specific considerations, and the implications for lifetime management strategies.
Author
Author
ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines
29 Aug 2021
There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...
Author
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
30 Oct 2024
Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.
Author
